Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 1303
Selected: 0
NCT IDTitle
NCT02171143A Dose Escalation Study to Assess Safety, Tolerability and Pharmacokinetics of ASP2409 Following a Single Intravenous Dose in Patients With Rheumatoid Arthritis on Methotrexate
NCT01536691Ramosetron, Aprepitant and Dexamethasone Versus Ondansetron, Aprepitant and Dexamethasone
NCT01742624Study to Evaluate the Safety and Efficacy of Advagraf vs Prograf in Kidney Transplantation Patients 1 Month After the Transplantation
NCT03192176A Dose-ranging Study of the Efficacy of ESN364 in Postmenopausal Women Suffering Vasomotor Symptoms (Hot Flashes)
NCT02291874Post-Marketing Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Ipragliflozin in Combination With GLP-1 Receptor Agonists in Japanese Patients With Type 2 Diabetes Mellitus (T2DM)
NCT01514825A Study to Investigate the Plasma Concentration of YM150 After Repeated Administration to Elderly Subjects
NCT02113813A Dose Escalation Study of ASP8273 in Subjects With Non-Small-Cell Lung Cancer (NSCLC) Who Have Epidermal Growth Factor Receptor (EGFR) Mutations
NCT02531191Bioequivalence Evaluation of a New and Current Tablet of ASP015K
NCT00595426A Study to Evaluate the Safety and Efficacy of YM150 in Patients With Knee Replacement Surgery
NCT01771705NFAT-Dependent Cytokine Gene Expression for Immune Monitoring in Kidney Transplant Patients
NCT07287995A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors
NCT03760081A Study to Assess the Safety and Efficacy of ASP1650, a Monoclonal Antibody Targeting Claudin 6 (CLDN6), in Male Subjects With Incurable Platinum Refractory Germ Cell Tumors
NCT00212628Controlled Study of ONO-5920 in Patients With Involutional Osteoporosis in Japan
NCT03945253Study of ASP8374, an Immune Checkpoint Inhibitor, in Japanese Patients With Advanced Solid Tumors
NCT05330377GM-CLAG in Relapsed/Refractory FLT3-mutated AML
NCT02461901Does Fidaxomicin Therapy Reduce Spread of Clostridium Difficile?
NCT01016054A Study of the Safety and Pharmacokinetics of AGS-8M4 Given in Combination With Chemotherapy in Women With Ovarian Cancer
NCT01638013A Study to Continue ASP015K Treatment to Rheumatoid Arthritis Patients Who Completed Phase IIb Study or Phase III Study of ASP015K
NCT01949337Enzalutamide With or Without Abiraterone and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate Cancer
NCT02605863Enzalutamide for Bladder Cancer Chemoprevention
NCT04878471Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ASP5354 in Healthy Adult Japanese Male Participants
NCT01284309A Study to Assess Intraocular Pressure and Ocular Safety of the Beta-3 Agonist Mirabegron in Research Subjects
NCT00036192Trial of FK614 in Type 2 Diabetics Inadequately Controlled on a Sulfonylurea
NCT01406132A Study to Assess the Pharmacokinetics of ASP015K in Healthy Male Subjects
NCT07421700Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
NCT05381311Survey Based Discrete Choice Experiment Study in Prostate Cancer (DECIDER) Study
NCT02320773A Prospective Non-interventional Study in Overactive Bladder (OAB) Patients Prescribed Betmiga® as Part of Routine Clinical Practice
NCT00510718A Phase 1 Study of MDV3100 in Patients With Castration-Resistant (Hormone-Refractory) Prostate Cancer
NCT04928703Effects of Ketamine on ERP/EEG Measures in Healthy Volunteers
NCT06505746A Study of Real-world Treatment of Adults With Urothelial Cancer in South Korea and Saudi Arabia
NCT02086188Study of Behavioral Modification Program and Mirabegron to Improve Urinary Urgency in Multiple Sclerosis
NCT02646774Post Marketing Study to Evaluate the Efficacy and Safety of Micafungin Treatment on Invasive Aspergillosis
NCT02805374A Food Effect Study to Evaluate the Pharmacokinetics of ASP1517
NCT02124668A Study to Monitor the Safety of Enzalutamide in Patients With Progressive Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy
NCT01877655A Study to Evaluate a Therapeutic Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seropositive Recipients Undergoing Allogeneic, Hematopoietic Cell Transplant (HCT)
NCT01777217VESIcare For Improving OAB Symptoms in Patients Undergoing IGRT of the Prostate
NCT01262391Single-dose Study to Assess Pharmacokinetics of Solifenacin Succinate Suspension in Children and Adolescents
NCT01646294A Study to Compare the Actions in the Body of Healthy Subjects of Three Modified Release Formulations of YM178 Under Fasted and Fed Conditions With One Immediate Release Formulation of YM178 Under Fasted Conditions
NCT01265537A Pilot Study Comparing the Use of Low-target Versus Conventional Target Advagraf
NCT01888445A Study to Investigate the Effect of ASP1517 After Intermittent Oral Dosing in Dialysis Chronic Kidney Disease Patients With Anemia Compared With Darbepoetin as a Reference Drug
NCT03288545A Study of Enfortumab Vedotin Alone or With Other Therapies for Treatment of Urothelial Cancer
NCT04143477A Study to Evaluate the Pharmacokinetics and Safety of ASP015K in Healthy Chinese Subjects
NCT00281541A Study for the Treatment of Unresectable Stage III or Metastatic Stage IV Melanoma
NCT00933231Comparison of Standard Versus Low Dose Advagraf® With or Without Angiotensin-converting Enzyme Inhibitor (ACEi)/Angiotensin Receptor Blocker (ARB) on Histology and Function of Renal Allografts
NCT02570841Pain Thresholds Under High-dose Topical Capsaicin
NCT01097681A Study to Assess the Pharmacokinetics, Pharmacodynamics of ASP1941 in Diabetes Mellitus Patients With Renal Impairment
NCT03328364A Registry Based Study Evaluating Overall Survival and Treatment Length in mCRPC Patients Treated With Enzalutamide in Sweden
NCT03653507A Study of Zolbetuximab (IMAB362) Plus CAPOX Compared With Placebo Plus CAPOX as First-line Treatment of Subjects With Claudin (CLDN) 18.2-positive, HER2-negative, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (GLOW).
NCT00868621Urinary Cytokines in Patients With Overactive Bladder (OAB)
NCT02128321A Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of Repaglinide and Caffeine